Jack Dean

Jack Dean

Direttore/Membro del Consiglio presso ACURX PHARMACEUTICALS, INC.

Patrimonio netto: 44 409 $ in data 31/05/2024

82 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Jack Hugh Dean was the founder of Dipexium Pharmaceuticals, Inc. (founded in 2010) and held the title of Director from 2010 to 2014.
He is currently working as a Director at ReSearch Pharmaceutical Services LLC since 2008, as an Independent Director at Acurx Pharmaceuticals, Inc. since 2021, as the President of Drug Development Advisors LLC since 2006, as a Trustee at ILSI Health & Environmental Sciences Institute since 1994, and as a Professor at the University of Arizona College of Pharmacy since 2006.
In his former positions, Dr. Dean worked as the Global Director-Preclinical Development at Sanofi from 1988 to 2006, as a Director at Sanofi-Synthelabo, Inc., as the Director of Sterling Winthrop Pharmaceuticals Research Center from 1990 to 1992, as the Director-Department of Immunology at Litton Bionetics, Inc. from 1975 to 1979, as the Vice President-Drug Safety at Sterling Winthrop, Inc. from 1989 to 1992, as the Head-National Toxicology Program at the National Institutes of Health from 1982 to 1988, as the President-US Science & Medical Affairs at Sanofi-Aventis U.S.
LLC from 1988 to 2006, as the Head-Immunotoxicology Section at The National Institute of Environmental Health Sciences from 1982 to 1988, and as the Head-Cellular & Molecular Toxicology Department at The Hamner Institutes for Health Sciences from 1982 to 1988.
Dr. Dean's education includes undergraduate and graduate degrees from The California State University and a doctorate degree from the University of Arizona College of Medicine (conferred in 1972).

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
17/06/2024 17 693 ( 0.11% ) 44 409 $ 31/05/2024

Posizioni attive di Jack Dean

SocietàPosizioneInizio
ACURX PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 24/06/2021
Direttore/Membro del Consiglio 12/05/2008
University of Arizona College of Pharmacy Corporate Officer/Principal 01/01/2006
ILSI Health & Environmental Sciences Institute Direttore/Membro del Consiglio 01/01/1994
Drug Development Advisors LLC Presidente 01/01/2006
Tutte le posizioni attive di Jack Dean

Precedenti posizioni note di Jack Dean

SocietàPosizioneFine
Direttore Tecnico/Scientifico/R&S 01/01/2006
SANOFI Corporate Officer/Principal 01/01/2006
Sterling Winthrop Pharmaceuticals Research Center Direttore/Membro del Consiglio 01/01/1992
Corporate Officer/Principal 01/01/1988
░░░ ░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Jack Dean

Formazione di Jack Dean

The California State University Graduate Degree
University of Arizona College of Medicine Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jack Dean

Relazioni

100 +

Relazioni di 1° grado

17

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
SANOFI

Health Technology

ACURX PHARMACEUTICALS, INC.

Health Technology

Aziende private12

Commercial Services

Health Technology

Sterling Winthrop Pharmaceuticals Research Center

Commercial Services

Commercial Services

Government

Drug Development Advisors LLC

Consumer Durables

Sanofi-Synthelabo, Inc.

Health Technology

Health Technology

ILSI Health & Environmental Sciences Institute

Litton Bionetics, Inc.

Vedi le connessioni aziendali